These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 30458163)
1. Cognitive decline in Tg2576 mice shows sex-specific differences and correlates with cerebral amyloid-beta. Schmid S; Rammes G; Blobner M; Kellermann K; Bratke S; Fendl D; Kaichuan Z; Schneider G; Jungwirth B Behav Brain Res; 2019 Feb; 359():408-417. PubMed ID: 30458163 [TBL] [Abstract][Full Text] [Related]
2. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease. Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747 [TBL] [Abstract][Full Text] [Related]
3. Impacts of aging and amyloid-β deposition on plasminogen activators and plasminogen activator inhibitor-1 in the Tg2576 mouse model of Alzheimer's disease. Bi Oh S; Suh N; Kim I; Lee JY Brain Res; 2015 Feb; 1597():159-67. PubMed ID: 25454795 [TBL] [Abstract][Full Text] [Related]
4. Cortical glucose metabolism is altered in aged transgenic Tg2576 mice that demonstrate Alzheimer plaque pathology. Bigl M; Apelt J; Eschrich K; Schliebs R J Neural Transm (Vienna); 2003 Jan; 110(1):77-94. PubMed ID: 12541014 [TBL] [Abstract][Full Text] [Related]
5. Alterations in cholinergic and non-cholinergic neurotransmitter receptor densities in transgenic Tg2576 mouse brain with beta-amyloid plaque pathology. Klingner M; Apelt J; Kumar A; Sorger D; Sabri O; Steinbach J; Scheunemann M; Schliebs R Int J Dev Neurosci; 2003 Nov; 21(7):357-69. PubMed ID: 14599482 [TBL] [Abstract][Full Text] [Related]
6. Icariin decreases both APP and Aβ levels and increases neurogenesis in the brain of Tg2576 mice. Li F; Dong HX; Gong QH; Wu Q; Jin F; Shi JS Neuroscience; 2015 Sep; 304():29-35. PubMed ID: 26079110 [TBL] [Abstract][Full Text] [Related]
7. Cognitive correlates of Abeta deposition in male and female mice bearing amyloid precursor protein and presenilin-1 mutant transgenes. Howlett DR; Richardson JC; Austin A; Parsons AA; Bate ST; Davies DC; Gonzalez MI Brain Res; 2004 Aug; 1017(1-2):130-6. PubMed ID: 15261108 [TBL] [Abstract][Full Text] [Related]
8. CHF5074 (CSP-1103) induces microglia alternative activation in plaque-free Tg2576 mice and primary glial cultures exposed to beta-amyloid. Porrini V; Lanzillotta A; Branca C; Benarese M; Parrella E; Lorenzini L; Calzà L; Flaibani R; Spano PF; Imbimbo BP; Pizzi M Neuroscience; 2015 Aug; 302():112-20. PubMed ID: 25450955 [TBL] [Abstract][Full Text] [Related]
9. Huatuo Zaizao pill ameliorates cognitive impairment of APP/PS1 transgenic mice by improving synaptic plasticity and reducing Aβ deposition. Zhang JH; Yu LJ; Yang H; Hui Z; Jiang S; Chen L; Zhao Y; Wang SL; Liu Y; Xu Y BMC Complement Altern Med; 2018 May; 18(1):167. PubMed ID: 29843688 [TBL] [Abstract][Full Text] [Related]
10. The evolution of A beta peptide burden in the APP23 transgenic mice: implications for A beta deposition in Alzheimer disease. Kuo YM; Beach TG; Sue LI; Scott S; Layne KJ; Kokjohn TA; Kalback WM; Luehrs DC; Vishnivetskaya TA; Abramowski D; Sturchler-Pierrat C; Staufenbiel M; Weller RO; Roher AE Mol Med; 2001 Sep; 7(9):609-18. PubMed ID: 11778650 [TBL] [Abstract][Full Text] [Related]
11. SEN1500, a novel oral amyloid-β aggregation inhibitor, attenuates brain pathology in a mouse model of Alzheimer's disease. Brunner D; Flunkert S; Neddens J; Duller S; Scopes DIC; Treherne JM; Hutter-Paier B Neurosci Lett; 2017 Nov; 660():96-102. PubMed ID: 28917978 [TBL] [Abstract][Full Text] [Related]
12. Synaptic Compensation as a Probable Cause of Prolonged Mild Cognitive Impairment in Alzheimer's Disease: Implications from a Transgenic Mouse Model of the Disease. Baazaoui N; Flory M; Iqbal K J Alzheimers Dis; 2017; 56(4):1385-1401. PubMed ID: 28222506 [TBL] [Abstract][Full Text] [Related]
13. Elevated A beta and apolipoprotein E in A betaPP transgenic mice and its relationship to amyloid accumulation in Alzheimer's disease. Kuo YM; Crawford F; Mullan M; Kokjohn TA; Emmerling MR; Weller RO; Roher AE Mol Med; 2000 May; 6(5):430-9. PubMed ID: 10952022 [TBL] [Abstract][Full Text] [Related]
14. Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression. Manczak M; Anekonda TS; Henson E; Park BS; Quinn J; Reddy PH Hum Mol Genet; 2006 May; 15(9):1437-49. PubMed ID: 16551656 [TBL] [Abstract][Full Text] [Related]
15. Differential contribution of APP metabolites to early cognitive deficits in a TgCRND8 mouse model of Alzheimer's disease. Hamm V; Héraud C; Bott JB; Herbeaux K; Strittmatter C; Mathis C; Goutagny R Sci Adv; 2017 Feb; 3(2):e1601068. PubMed ID: 28275722 [TBL] [Abstract][Full Text] [Related]
16. An Intranasal Formulation of Erythropoietin (Neuro-EPO) Prevents Memory Deficits and Amyloid Toxicity in the APPSwe Transgenic Mouse Model of Alzheimer's Disease. Rodríguez Cruz Y; Strehaiano M; Rodríguez Obaya T; García Rodríguez JC; Maurice T J Alzheimers Dis; 2017; 55(1):231-248. PubMed ID: 27662300 [TBL] [Abstract][Full Text] [Related]
18. Tripchlorolide improves cognitive deficits by reducing amyloid β and upregulating synapse-related proteins in a transgenic model of Alzheimer's Disease. Zeng Y; Zhang J; Zhu Y; Zhang J; Shen H; Lu J; Pan X; Lin N; Dai X; Zhou M; Chen X J Neurochem; 2015 Apr; 133(1):38-52. PubMed ID: 25661995 [TBL] [Abstract][Full Text] [Related]
19. Comparative studies using the Morris water maze to assess spatial memory deficits in two transgenic mouse models of Alzheimer's disease. Edwards SR; Hamlin AS; Marks N; Coulson EJ; Smith MT Clin Exp Pharmacol Physiol; 2014 Oct; 41(10):798-806. PubMed ID: 25115283 [TBL] [Abstract][Full Text] [Related]